According to Hester Biosciences
's latest financial reports the company has $3.86 M in cash and cash equivalents.
A companyโs cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Year | Cash on Hand | Change |
---|---|---|
2023-03-31 | $1.68 M | -49.47% |
2022-03-31 | $3.32 M | 15.77% |
2021-03-31 | $2.87 M | -7.38% |
2020-03-31 | $3.1 M | -47.02% |
2019-03-31 | $5.85 M | 191.45% |
2018-03-31 | $2 M | 15.91% |
2017-03-31 | $1.73 M | 132.53% |
2016-03-31 | $0.74 M | -29.25% |
2015-03-31 | $1.05 M | 29.89% |
2014-03-31 | $0.81 M | 67.45% |
2013-03-31 | $0.48 M | -33.42% |
2012-03-31 | $0.72 M | 103.72% |
2011-03-31 | $0.35 M |